MAPKAPK2 and vitiligo: This study intended to investigate whether epigenetic downregulation of MAPKAPK2 aggravates oxidative stress-induced damage in vitiligo melanocytes.<h4>Methods</h4>Human melanocyte lines (PIG1 and PIG3V) were used to model normal and vitiligo conditions.